GUABER S.P.A. - search results

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

siofor 500 tablets film-coated

berlin-chemie ag - metformin (metformin hydrochloride) - tablets film-coated - 500mg

siofor 500 tablets film-coated

berlin-chemie ag - metformin (metformin hydrochloride) - tablets film-coated - 500mg

siofor 850 tablets film-coated

berlin-chemie ag - metformin (metformin hydrochloride) - tablets film-coated - 850mg

siofor 850 tablets film-coated

berlin-chemie ag - metformin (metformin hydrochloride) - tablets film-coated - 850mg

United States - English - NLM (National Library of Medicine)

tubersol- tuberculin purified protein derivative injection, solution

sanofi pasteur inc. - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tubersol tuberculin purified protein derivative (mantoux), is indicated to aid diagnosis of tuberculosis infection (tb) in persons at increased risk of developing active disease. the centers for disease control and prevention (cdc) have published guidelines regarding populations that would benefit from tuberculin skin testing (tst). current recommendations can be accessed at: http://www.cdc.gov/tb/publications/factsheets/testing.htm. previous bcg vaccination is not a contraindication to tuberculin testing. the skin-test results of bcg vaccinated persons can be used to support or exclude the diagnosis of tb infection. however, an fda-approved interferon gamma release assay is preferred over tuberculin skin test for persons 5 years of age and older who were previously vaccinated with bcg. (8) allergy to any component of tubersol or an anaphylactic or other allergic reaction to a previous test of tuberculin ppd is a contraindication to the use of tubersol. (see description and how supplied.) tubersol should not be administered to: - persons who have had a severe reaction (e.g., necrosis, blistering, anaphylactic shock, or ulcerations) to a previous tst, - persons with documented active tuberculosis or a clear history of treatment for tb infection or disease, (9) - persons with extensive burns or eczema.

United States - English - NLM (National Library of Medicine)

tubersol- tuberculin purified protein derivative injection, solution

physicians total care, inc. - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tubersol, tuberculin purified protein derivative (mantoux), is indicated to aid diagnosis of tuberculosis infection (tb) in persons at increased risk of developing active disease. the centers for disease control and prevention (cdc) have published guidelines regarding populations that would benefit from tuberculin skin testing (tst). current recommendations can be accessed at: http://www.cdc.gov/tb/publications/factsheets/testing.htm. previous bcg vaccination is not a contraindication to tuberculin testing. the skin-test results of bcg vaccinated persons can be used to support or exclude the diagnosis of tb infection. however, an fda-approved interferon gamma release assay is preferred over tuberculin skin test for persons 5 years of age and older who were previously vaccinated with bcg. (9) allergy to any component of tubersol or an anaphylactic or other allergic reaction to a previous test of tuberculin ppd is a contraindication to the use of tubersol. (see description and how supplied) tubersol should not

United States - English - NLM (National Library of Medicine)

tubersol- tuberculin purified protein derivative injection, solution

a-s medication solutions - tuberculin purified protein derivative (unii: i7l8fkn87j) (tuberculin purified protein derivative - unii:i7l8fkn87j) - tuberculin purified protein derivative 5 [iu] in 0.1 ml - tubersol tuberculin purified protein derivative (mantoux), is indicated to aid diagnosis of tuberculosis infection (tb) in persons at increased risk of developing active disease. the centers for disease control and prevention (cdc) have published guidelines regarding populations that would benefit from tuberculin skin testing (tst). current recommendations can be accessed at: http://www.cdc.gov/tb/publications/factsheets/testing.htm. previous bcg vaccination is not a contraindication to tuberculin testing. the skin-test results of bcg vaccinated persons can be used to support or exclude the diagnosis of tb infection. however, an fda-approved interferon gamma release assay is preferred over tuberculin skin test for persons 5 years of age and older who were previously vaccinated with bcg. (8) allergy to any component of tubersol or an anaphylactic or other allergic reaction to a previous test of tuberculin ppd is a contraindication to the use of tubersol. (see description and how supplied.) tubersol should not

Israel - English - Ministry of Health

tubersol

sanofi israel ltd - tuberculin purified protein - solution for injection - tuberculin purified protein 5 tu / 0.1 ml - tuberculosis diagnostics - an aid in the detection of infection with mycobacterium tuberculosis.

Ireland - English - HPRA (Health Products Regulatory Authority)

tuberculin ppd rt 2 t.u. /0.1 ml solution for injection

statens serum institute - tuberculin ppd - solution for injection - 2 t.u. /0.1 ml - tuberculosis diagnostics

Ireland - English - HPRA (Health Products Regulatory Authority)

tuberculin ppd rt 10 t.u. /0.1 ml solution for injection

statens serum institute - tuberculin ppd - solution for injection - 10 t.u. /0.1 ml - tuberculosis diagnostics